Key facts
- It has raised $13.2M; the latest was Accelerator/Incubator in Jan 2025.
- Notable investors include Caelestinus, AG2R La Mondiale, Caisse des Depots Group, Sofiouest, Avolta Partners — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Posos
- ·The full record, as it builds
Funding rounds
No funding rounds for Posos are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Posos
Developer of a support tool designed for prescription management and making decisions about patient care. The company's tool helps caregivers identify iatrogenic risks at every step of the patient journey, analyzes prescriptions in real time, identifies potential risks, and provides personalized recommendations for medication management, enabling healthcare professionals to provide safer, effective care for their patients.
- Sector
- Healthcare
- HQ
- Amiens, France
- Founded
- 2017
- Employees
- 40
- Website
- posos.co/
- Ownership
- Privately Held (backing)
Posos doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Posos shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Posos in its N-PORT filings yet. We sweep new filings monthly.